| Idiopathic pulmonary fibrosis (IPF): an overview SL Barratt, A Creamer, C Hayton, N Chaudhuri Journal of clinical medicine 7 (8), 201, 2018 | 379 | 2018 |
| Drug-induced interstitial lung disease: a systematic review S Skeoch, N Weatherley, AJ Swift, A Oldroyd, C Johns, C Hayton, A Giollo, ... Journal of clinical medicine 7 (10), 356, 2018 | 354 | 2018 |
| Barriers to pulmonary rehabilitation: characteristics that predict patient attendance and adherence C Hayton, A Clark, S Olive, P Browne, P Galey, E Knights, L Staunton, ... Respiratory medicine 107 (3), 401-407, 2013 | 326 | 2013 |
| Nintedanib in the management of idiopathic pulmonary fibrosis: clinical trial evidence and real-world experience P Rivera-Ortega, C Hayton, J Blaikley, C Leonard, N Chaudhuri Therapeutic Advances in Respiratory Disease 12, 1753466618800618, 2018 | 88 | 2018 |
| Breath biomarkers in idiopathic pulmonary fibrosis: a systematic review C Hayton, D Terrington, AM Wilson, N Chaudhuri, C Leonard, SJ Fowler Respiratory research 20, 1-16, 2019 | 37 | 2019 |
| Idiopathic pulmonary fibrosis: a holistic approach to disease management in the antifibrotic age J Shaw, T Marshall, H Morris, C Hayton, N Chaudhuri Journal of thoracic disease 9 (11), 4700, 2017 | 26 | 2017 |
| Managing idiopathic pulmonary fibrosis: which drug for which patient? C Hayton, N Chaudhuri Drugs & aging 34, 647-653, 2017 | 20 | 2017 |
| Transbronchial lung cryobiopsy in idiopathic pulmonary fibrosis: a state of the art review T Lodhi, G Hughes, S Stanel, N Chaudhuri, C Hayton Advances in therapy 36, 2193-2204, 2019 | 19 | 2019 |
| The role of measuring exhaled breath biomarkers in sarcoidosis: a systematic review DL Terrington, C Hayton, A Peel, SJ Fowler, W Fraser, AM Wilson Journal of breath research 13 (3), 036015, 2019 | 18 | 2019 |
| Current treatments in the management of idiopathic pulmonary fibrosis: pirfenidone and nintedanib C Hayton, N Chaudhuri Clinical Medicine Insights: Therapeutics 9, 1179559X17719126, 2017 | 12 | 2017 |
| The detection, assessment and clinical evolution of interstitial lung abnormalities identified through lung cancer screening H Balata, A Punjabi, N Chaudhuri, M Greaves, J Yorke, R Booton, ... ERJ Open Research 9 (3), 2023 | 11 | 2023 |
| Changes in lung epithelial cell volatile metabolite profile induced by pro-fibrotic stimulation with TGF-β1 C Hayton, W Ahmed, P Cunningham, K Piper-Hanley, L Pearmain, ... Journal of Breath Research 17 (4), 046012, 2023 | 3 | 2023 |
| Antifibrotic choice in idiopathic pulmonary fibrosis C Hayton, H Morris, T Marshall, K Zakis, T Garfoot, PR Ortega, M Greaves, ... European Respiratory Journal 52 (suppl 62), 2018 | 3 | 2018 |
| P30 Real-world tolerability study of nintedanib in patients with progressive fibrosing interstitial lung disease compared to patients with idiopathic pulmonary fibrosis K Newman, T Garfoot, L Stranks, H Morris, K Zakis, J Swale, M Greaves, ... Thorax 77 (Suppl 1), A96-A96, 2022 | 2 | 2022 |
| Effectiveness of Fan therapy in breathlessness management in Fibrotic Interstitial lung disease. H Morris, K Zakis, J Swale, C Hayton European Respiratory Journal 60 (suppl 66), 2022 | 2 | 2022 |
| Exhaled volatile organic compounds in idiopathic pulmonary fibrosis and disease progression C Hayton, D Terrington, W Ahmed, I White, M Wilkinson, K Vekaria, ... European Respiratory Journal 56 (suppl 64), 2020 | 2 | 2020 |
| Introducing a new formulation of pirfenidone to reduce tablet burden for the IPF patient: Is it tolerable? Is it easy to take? What do our patients think? H Morris, T Marshall, K Zakis, T Garfoot, C Hayton, PR Ortega, C Leonard, ... European Respiratory Journal 52 (suppl 62), 2018 | 2 | 2018 |
| What can we learn from idiopathic pulmonary fibrosis registries? T Lodhi, C Leonard, PR Ortega, H Morris, T Marshall, K Zakis, T Garfoot, ... European Respiratory Journal 52 (suppl 62), 2018 | 2 | 2018 |
| P221 Silicosis and mycobacterium disease: is it a problem in the uk? C Hayton, J Hoyle Thorax 72 (Suppl 3), A203-A205, 2017 | 2 | 2017 |
| Mycophenolate and azathioprine efficacy in interstitial lung disease: a systematic review and meta-analysis F Lombardi, I Stewart, L Fabbri, W Adams, L Kawano-Dourado, ... BMJ Open Respiratory Research 11 (1), e002163, 2024 | 1 | 2024 |
nazia chaudhuriUniversity of UlsterVahvistettu sähköpostiosoite verkkotunnuksessa nhs.net
